
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
---|---|---|---|---|---|---|
09/30/2025 | Q3 | $70.2B | -- | -- | $1.58 | -- |
08/01/2025 | Q2 | $66.2B | -- | -- | $1.36 | -- |
05/02/2025 | Q1 | $79.1B | $69.2B | $1.58 | $1.61 | -$0.03 |
01/30/2025 | Q4 | $71.8B | $66.3B | $0.30 | $1.49 | -$1.19 |
10/31/2024 | Q3 | $78B | $71.1B | $1.36 | $1.70 | -$0.34 |
08/01/2024 | Q2 | $90.3B | $74.5B | $1.10 | $1.78 | -$0.68 |
05/02/2024 | Q1 | $88.1B | $72.5B | $2.26 | $1.92 | $0.34 |
02/01/2024 | Q4 | $86.3B | $78.7B | $0.14 | $1.86 | -$1.72 |
11/02/2023 | Q3 | $65.1B | $76.4B | $2.10 | $1.92 | $0.18 |
07/27/2023 | Q2 | $79.2B | $74.6B | $0.92 | $1.61 | -$0.69 |
05/04/2023 | Q1 | -- | $87B | $2.50 | -- | -- |
02/02/2023 | Q4 | -- | $101.3B | $2.92 | -- | -- |
10/27/2022 | Q3 | -- | $95.7B | $1.84 | -- | -- |
07/28/2022 | Q2 | -- | $100.1B | $4.80 | -- | -- |
05/05/2022 | Q1 | -- | $84.2B | $1.86 | -- | -- |
02/03/2022 | Q4 | -- | $85.3B | $2.96 | -- | -- |
09/30/2021 | Q3 | -- | $60B | -$0.12 | -- | -- |
06/30/2021 | Q2 | -- | $60.5B | $0.88 | -- | -- |
03/31/2021 | Q1 | -- | $55.7B | $1.44 | -- | -- |
12/31/2020 | Q4 | -- | $44B | -$1.04 | -- | -- |
09/30/2020 | Q3 | -- | $44B | $0.12 | -- | -- |
06/30/2020 | Q2 | -- | $32.5B | -$4.66 | -- | -- |
03/31/2020 | Q1 | -- | $60B | -$0.01 | -- | -- |
12/31/2019 | Q4 | -- | $84B | $0.24 | -- | -- |
09/30/2019 | Q3 | -- | $86.6B | $1.46 | -- | -- |
06/30/2019 | Q2 | -- | $90.5B | $0.74 | -- | -- |
03/31/2019 | Q1 | -- | $83.7B | $1.46 | -- | -- |
12/31/2018 | Q4 | -- | $102.2B | $1.34 | -- | -- |
09/30/2018 | Q3 | -- | $100.2B | $1.40 | -- | -- |
06/30/2018 | Q2 | -- | $96.8B | $1.44 | -- | -- |
03/31/2018 | Q1 | -- | $89.2B | $1.40 | -- | -- |
12/31/2017 | Q4 | -- | $85.4B | $0.92 | -- | -- |
09/30/2017 | Q3 | -- | $75.8B | $1.00 | -- | -- |
06/30/2017 | Q2 | -- | $72.1B | $0.38 | -- | -- |
03/31/2017 | Q1 | -- | $71.8B | $0.86 | -- | -- |
12/31/2016 | Q4 | -- | $64.8B | $0.38 | -- | -- |
09/30/2016 | Q3 | -- | $61.9B | $0.34 | -- | -- |
06/30/2016 | Q2 | -- | $58.4B | $0.30 | -- | -- |
03/31/2016 | Q1 | -- | $48.6B | $0.14 | -- | -- |
12/31/2015 | Q4 | -- | $58.1B | $0.30 | -- | -- |
09/30/2015 | Q3 | -- | $68.7B | -$2.34 | -- | -- |
Shell PLC reported $69.2B worth of top line sales in its most recent quarter.
Shell PLC announced earnings per share of $1.58 which represents a miss of analyst forecast a $1.61 per share.
Shell PLC reported $12.7B that represents $4.17 per share over the last quarter.
Shell PLC's earnings are forecast to grow from $5.06 per share to $7.93 per share next year representing an increase of 19.92%.
Shell PLC's next earnings date is August 1, 2025.
Signup to receive the latest stock alerts
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Market Cap: $4.2T
P/E Ratio: 58x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 35x
SharpLink Gaming [SBET] is down 2.6% over the past day.
Exodus Movement [EXOD] is down 4.14% over the past day.
Unity Software [U] is up 7.51% over the past day.